To address this gap in the literature and provide bespoke recommendations for supporting HCL use in pregnancy, we report findings from interviews with healthcare professionals who participated in a UK-based, multicenter, randomized controlled trial—Automated insulin Delivery Amongst Pregnant women with Type 1 diabetes (AiDAPT). The gene discussed is INS; the disease is type 1 diabetes mellitus.